• Non ci sono risultati.

Harlequin Ichthyosis (Harlequin Fetus)

N/A
N/A
Protected

Academic year: 2022

Condividi "Harlequin Ichthyosis (Harlequin Fetus)"

Copied!
3
0
0

Testo completo

(1)

Harlequin ichthyosis is a rare severe scaling disorder, which manifests in utero and is often fatal early in life.

GENETICS/BASIC DEFECTS

1. Inheritance: autosomal recessive 2. Pathogenesis

a. Lack of desquamation and massive accumulation of scale due to abnormal lamellar granules and absence of extracellular lamellar structures between the granular cells and the cornified cells

b. Defect in lipid synthesis or metabolism

c. A defect of conversion from profilaggrin to filaggrin i. Suggests possible defects of protein phosphatase

activity in the epidermis

ii. Leads to the clinical features of harlequin ichthyosis because protein phosphatase is thought to work both in the conversion from profilag- grin to filaggrin and in the synthesis of the lipid content of lamellar granules

3. Report of a male with harlequin ichthyosis with a de novo deletion of the long arm of chromosome 18 [46, XY, del(18)(q21.3)] suggesting the possible gene localization within the deleted region

CLINICAL FEATURES

1. Major clinical features

a. Large, thick and yellowish armor-like plaques (plate- like scales) with redish, moist, oozing fissures and cracks, covering the whole body

b. Severe ectropion (complete eversion of the nonkera- tinizing mucosa of the eyelids with occlusion of the eyes)

c. Eclabium (eversion of the nonkeratinizing mucosa of the lips)

d. “Frog-like” grostesque appearance of the face e. Crumpled and flattened ears

f. Flattened nasal tip with anteversion of the nares (nasal hypoplasia)

g. Permanently opened mouth unable to suck properly h. Swollen extremities secondary to tight sausage-like

encasement by the thickened stratum corneum i. Semiflexed rigid extremities (allowing little limb

movement) with hypoplastic fingers 2. Minor clinical features

a. Absent eyebrows and eyelashes b. Scalp hair may or may not be present 3. Associate anomalies

a. Renal tubular defects b. Altered thymic structures c. Pulmonary hypoplasia

4. Natural history

a. Restricted fetal movement caused by dense masses of hyperkeratotic scale

b. Prematurity in most cases

c. Perinatal death (usually in the first few weeks) secondary to:

i. Respiratory compromise due to mechanical lim- itation of ribcage excursion

ii. Sepsis iii. Hypothermia

iv. Dehydration v. Malnutrition vi. Severe anemia vii. Renal failure d. Rare survivals

i. Variable neurologic impairment ii. Short stature

iii. Failure to thrive

iv At risk for severe keratitis due to ectropion of all eyelids

DIAGNOSTIC INVESTIGATIONS

1. Light microscopy findings

a. Extraordinary compact orthohyperkeratosis (thick- ened orthokeratotic stratum corneum)

b. Keratin plugs in hair follicles and sweat ducts c. Absent lamellar bodies and abundant vesicles in both

the stratum granulosum and stratum corneum d. Abnormal lipid droplets and vacuoles in the cytoplasm

of keratinized cells in the thick stratum corneum 2. Ultrastructural findings

a. Abnormal lipid droplets and vacuoles in the cytoplasm of keratinized cells in the thick stratum corneum b. Absent normal lamellar granules in the cytoplasm of

granular layer keratinocytes

c. Lack of lamellar structure in the extracellular space between the first cornified cell and the granular cell 3. Biochemical analysis of skin samples: a defect of conver-

sion from profilaggrin to filaggrin

4. Family history for evidence of consanguinity

GENETIC COUNSELING

1. Recurrence risk a. Patient’s sib: 25%

b. Patient’s offspring: patient not surviving to reproductive age

2. Prenatal diagnosis possible in families at risk

a. Ultrasonography (2D and especially 3D) after 24 weeks i. Minimal fetal movement with stiff limbs in a

semiflexed position

473

Harlequin Ichthyosis (Harlequin Fetus)

(2)

474 HARLEQUIN ICHTHYOSIS (HARLEQUIN FETUS)

ii. Swollen limbs with hypoplastic fingers and toes and short phalanges

iii. Shriveled hands that do not open iv. Abnormal facies

v. Absence of typical ear morphology vi. Large open mouth

vii. Absence of typical nasal morphology

viii. Partitioned cystic formations in front of the eyes ix. Thick skin

x. Hyperechogenic amniotic fluid

xi. Absence of associated visceral anomalies b. Amniocentesis: demonstration of clumping of ker-

atinocyte cells in the amniotic fluid containing lipid droplets and amorphous electron dense material c. Electron microscopy of the fetal skin biopsy speci-

men from fetoscopy at 20-22 weeks i. Abnormal vacuoles in keratinized cells ii. Abnormal lamellar granules in the hair canal 3. Management

a. Temperature control

b. Electrolyte and fluid balance c. Adequate caloric intake

d. Prevention of infection with antibiotics

e. Topical steroids to reduce secondary inflammation f. Tretinoin creams or ointments or oral retinoid treat-

ment to reduce the amount of scale

g. Pain management with anti-inflammatory drugs and morphine sulfate if necessary

h. Ocular management

i. Intensive topical eye ointment ii. Treat keratitis promptly

iii. Surgical management of the ectropion by skin- release surgery with autologous skin grafting in patients with severe exposure keratitis or cos- metically unacceptable ectropion

i. Careful handling to avoid hard friction and physical contract for prevention of blistering

REFERENCES

Akiyama M: Severe congenital ichthyosis of the neonate. Int J Dermatol 37:722–728, 1998.

Akiyama M, Suzumori K, Shimizu H: Prenatal diagnosis of harlequin ichthyosis by the examination of keratinized hair canals and amniotic

fluid cells at 19 weeks’ estimated gestational age. Prenat Diagn 19:167–171, 1999.

Akiyama M, Dale BA, Smith LT, et al.: Regional difference in expression of characteristic abnormality of harlequin ichthyosis in affected fetuses.

Prenat Diagn 18:425–436, 1998.

Anton-Lamprecht I: Genetically induced abnormalities of epidermal differenti- ation and ultrastructure in ichthyoses and epidermolyses: pathogenesis, heterogeneity, fetal manifestation, and prenatal diagnosis. J Inv Dermatol 81 (suppl):149S–156S, 1983.

Badden HP, Kubilus J, Rosenbaum K, et al.: Keratinization in the harlequin fetus. Arch Dermatol 118:14–18, 1982.

Blanchet-Bardon S, Dumez Y, Labbe F, et al.: Prenatal diagnosis of a harlequin fetus using EM. Ann Pathol 3:321–325, 1983.

Bongain A, Benoit B, Ejnes L, et al.: Harlequin fetus: three-dimensional sono- graphic findings and new diagnostic approach. Ultrasound Obstet Gynecol 20:82–85, 2002.

Buxman MM, Goodkin PE, Fahrenback WH, et al.: Harlequin ichthyosis with an epidermal lipid abnormality. Arch Dermatol 115:189–193, 1979.

Craig JM, Goldsmith LA, Baden HP: An abnormality of keratin in the harle- quin fetus. Pediatrics 46:437–440, 1970.

Dale BA, Holbrook KA, Fleckman P, et al.: Heterogeneity in Harlequin ichthyosis, an inborn error of epidermal keratinization: vVariable mor- phology and structural protein expression and a defect in lamellar granules.

J Inv Dermatol 94:6–18, 1990.

Dale BA ,Kam E: Harlequin ichthyosis. Variability in expression and hypothe- sis for disease mechanism. Arch Dermatol 129:1471–1477, 1993.

Hashimoto K, Khan S: Harlequin fetus with abnormal lamellar granules and giant mitochondria. J Cutan Pathol 19:247–252, 1992.

Haftek M, Cambazard F, Dhouailly D, et al.: A longitudinal study of a harle- quin infant presenting clinically as non-bullous congenital ichthyosiform erythroderma. Br J Dermatol 135:448–453, 1996.

Moreau S, Salame E, Goullet de Rugy M, et al.: Harlequin fetus: a case report.

Surg Radiol Anat 21:215–216, 1999.

Multani AS, Sheth FJ, Shah VC, et al.: Three siblings with harlequin ichthyosis in an Indian family. Early Hum Dev 45:229–233, 1996.

Prasad RS, Pejaver RK, Hassan A, et al.: Management and follow-up of harle- quin siblings. Br J Dermatol 130:650–653, 1994.

Roberts LJ: Long-term survival of a harlequin fetus. J Am Acad Dermatol 21:335–339, 1989.

Sarkar R, Sharma RC, Sethi S, et al.: Three unusual siblings with harlequin ichthyosis in an Indian family. J Dermatol 27:609–611, 2000.

Singh S, Bhura M, Maheshwari A, et al.: Successful treatment of harlequin ichthyosis with acitretin. Int J Dermatol 40:472–473, 2001.

Stewart H, Smith PT, Gaunt L, et al.: De novo deletion of chromosome 18q in a baby with harlequin ichthyosis. Am J Med Genet 102:342–345, 2001.

Sybert VP: Genetic Skin Disorders. New York: Oxford University Press, 1997, pp 13–16.

Unamuno P, Pierola JM, Fernandez E, et al.: Harlequin foetus in four siblings.

Br J Dermatol 116:569–572, 1987.

Watson WJ, Mabee LM, Jr: Prenatal diagnosis of severe congenital ichthyosis (harlequin fetus) by ultrasonography. J Ultrasound Med 14:241–243, 1995.

(3)

HARLEQUIN ICHTHYOSIS (HARLEQUIN FETUS) 475

Fig. 1. A newborn with harlequin ichthyosis, covered with yellowish plaques with moist fissures and cracks and grostesque appearance of face with ectropion, eclabium, a flat nose, crumpled/flat ears, and swollen/semiflexed rigid limbs.

Riferimenti

Documenti correlati

harlequin ladybird Harmonia axyridis (Coleoptera: Coccinellidae), an active predator of aphids, which has raised concern because of its invasiveness. The current studies

institutional parties, and the political parties that are now registered, and all the trade unions, whether they are the institutionalized ones, Cgil, Cisl, Uil, or

principio di giustizia fiscale e a distorsioni nel movimento dei capitali e nelle condizioni di concorrenza, il Consiglio, in data 10 febbraio 1975, ha adottato una

As an example, in SMA drug discovery, the 3,6-disubstituted pyridazine was identified through High-throughput screening in the NSC-34 cell line containing a SMN2 minigene reporter,

The excluded cross section at 95% CL for the Jet-Jet model (upper left) and the B-Lepton model (upper right) as a function of the mass and proper decay length of the parent

We report the number of subjects and gesture classes and the types of data included: RGB images, depth maps (acquired with Structured Light (SL) or Time-of-Flight (ToF)

18 In view of the single-agent activity and demonstrated synergy between cyclophosphamide and fludarabine, and between fludarabine and rituximab, we evaluated the combination

Processi di medicalizzazione, cittadinanza e legami familiari Torino, 17-18-19 giugno 2015 (Aula Magna Campus Luigi Einaudi). a cura di Simona T aliani Ai nostri lettori 9